Loading...
Intravitreal bevacizumab administration for the treatment of chronic central serous chorioretinopathy
PURPOSE: To evaluate the effects of intravitreal bevacizumab (IVB) injection on chronic central serous chorioretinopathy (CSC). METHODS: In this prospective interventional case series, a total of 22 eyes of 22 patients, diagnosed with unresolved CSC for three months or longer, received 1.25 mg IVB i...
Saved in:
| Published in: | J Curr Ophthalmol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Elsevier
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6896463/ https://ncbi.nlm.nih.gov/pubmed/31844791 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.joco.2019.06.006 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|